About Gene List

PF3D7_1227100 (DH60)

Genome location: Pf3D7_12_v3:1,092,884..1,096,419(-)

Genome classification: Core

Function and Localization

Product Description: DNA helicase 60

SignalP Peptide: N/A

# Transmembrane Domains: 0

EC Numbers: 3.6.4.12 (DNA helicase)

Curated GO (PlasmoDB):

Type GO Term Name
Component GO:0005634 nucleus
Function GO:0033679 3'-5' DNA/RNA helicase activity
Function GO:0033678 5'-3' DNA/RNA helicase activity
Function GO:0005524 ATP binding
Function GO:0016887 ATP hydrolysis activity
Function GO:0003723 RNA binding
Function GO:0003724 RNA helicase activity
Function GO:0003729 mRNA binding
Process GO:0016070 RNA metabolic process

Expression by stage (LR - Le Roch et al., and MCA - Malaria Cell Atlas):

Stage LR class MCA mean MCA prop. zeros
Sporozoite expressed N/A N/A
Ring expressed 0.09 0.95
Trophozoite expressed 0.42 0.75
Schizont expressed 0.06 0.96
Gametocyte expressed 0.24 0.85

More info:

Resistome Mutations

Old (Pf3D7v3) Gene ID: PF3D7_1227100

Resistome Missense Mutations: None

Resistome Compounds with Missense Mutations: None

Resistome # Samples with Disruptive Mutations: 0 (0 missense, 0 "interesting" missense)

Essentiality (ABS)

Zhang Phenotype: Mutable in CDS

MIS: 1 | MFS: 0.194 | #Insertions: 2

PlasmoGEM Phenotype: N/A

RMgmDB ABS Phenotype: N/A

More info: PhenoPlasm Link

Binding Evidence

AlphaFill Uniprot ID: Q8I5E7

"Best" AlphaFill ligand hit: ADP (adenosine-5'-diphosphate, Local RMSD=0.03) with 3RRM (Global RMSD=6.99)

BRENDA EC Inhibitors:

EC # Name EC Inhibitors
3.6.4.12 DNA helicase No BRENDA inhibitors

No evidence of orthology to BindingDB entries

Orthology Information

Ortholog Group (OrthoMCL): OG6_167010

No human ortholog(s)

Genetic Variation

MalariaGEN Pf7 (worldwide samples) # unique SNV/indels:

Homozygous genotype calls only

variant type common rare doubleton singleton
synonymous 10 26 20 50
disruptive 45 105 53 131
missense 19 55 42 93

Any inclusion in genotype call

variant type common rare doubleton singleton
synonymous 16 68 29 40
disruptive 75 193 96 206
missense 34 118 75 129

PlasmoDB Total SNPs: 181

Non-coding: 118 | Synonymous: 43 | Nonsynonymous: 20 | Stop Codon: 0

Protein Information

Protein Length: 742 | Molecular Weight (kDa): 87.02

UniProt ID(s): Q66WQ1, Q8I5E7

PDB ID(s): None

Isoelectric Point: 8.12

Protein Domain Annotations:

Source Family ID Description
InterPro IPR000629 ATP-dependent RNA helicase DEAD-box, conserved site
InterPro IPR001650 Helicase, C-terminal
InterPro IPR011545 DEAD/DEAH box helicase domain
InterPro IPR014001 Helicase superfamily 1/2, ATP-binding domain
InterPro IPR027417 P-loop containing nucleoside triphosphate hydrolase
PFam PF00270 DEAD/DEAH box helicase domain
PFam PF00271 Helicase, C-terminal
Superfamily SSF52540 P-loop containing nucleoside triphosphate hydrolase

Associated Publications

PMID Title Authors DOI/Link
12368864 Genome sequence of the human malaria parasite Plasmodium falciparum. Gardner MJ, Hall N, ..., Barrell B 10.1038/nature01097
16165232 Plasmodium falciparum DNA helicase 60 is a schizont stage specific, bipolar anddual helicase stimulated by PKC phosphorylation. Pradhan A, Chauhan VS, Tuteja R https://pubmed.ncbi.nlm.nih.gov/16165232/
17378213 'DEAD-box' helicase from Plasmodium falciparum is active at wide pH and isschizont stage-specific. Pradhan A, Chauhan VS, Tuteja R https://pubmed.ncbi.nlm.nih.gov/17378213/
23181666 Organellar proteomics reveals hundreds of novel nuclear proteins in the malariaparasite Plasmodium falciparum. Oehring SC, Woodcroft BJ, ..., Voss TS 10.1186/gb-2012-13-11-r108
27381095 The mRNA-bound proteome of the human malaria parasite Plasmodium falciparum. Bunnik EM, Batugedara G, ..., Le Roch KG 10.1186/s13059-016-1014-0
30379851 Identification of Plasmodium falciparum nuclear proteins by mass spectrometry andproposed protein annotation. Briquet S, Ourimi A, ..., Vaquero C 10.1371/journal.pone.0205596
15694486 A novel 'DEAD-box' DNA helicase from Plasmodium falciparum is homologous to p68 Pradhan A, Chauhan VS, Tuteja R 10.1016/j.molbiopara.2004.12.004
23916206 Selection of antimalarial drug resistance after intermittent preventive treatmentof infants and children (IPTi/c) in Senegal Ndiaye M, Tine R, ..., Gaye O 10.1016/j.crvi.2013.04.016